Furopyridine compounds for the treatment of hepatitis C

US9957278B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Tao Wang · Farmington, US
• Kyle J. Eastman · New Haven, US
• Zhongxing Zhang · Wallingford, US
• Kyle E. Parcella · Wallingford, US
• John F. Kadow · Wallingford, US

Key dates

• Filing date: Aug 4, 2015
• Grant date: May 1, 2018
• Expiry date: Aug 4, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07B2200/05
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.